Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, 7 Chung-Shan South Road, Zhong-Zheng District, Taipei, 100, Taiwan.
J Cancer Res Clin Oncol. 2014 Apr;140(4):613-21. doi: 10.1007/s00432-014-1600-z. Epub 2014 Feb 13.
Acute kidney injury (AKI) is gaining worldwide attention recently, emerging as a major public health threat. However, the association between the development of AKI and subsequent malignancy has not been studied before.
We conducted a population study based on the Taiwan National Health Insurance database, using 1,000,000 representative database during 2000-2008. All patients' survival to discharge from index hospitalization with recovery from dialysis-requiring AKI were identified (recovery group), and matched with those without recovery and those without AKI, at a 1:1:1 ratio.
We identified 625 individuals more than 18 years old [352 male (56.5%); mean age, 63.3 years] in recovery group and matched 625 individuals in each group. During a mean followed-up of 3.7 years, the incidences of new-onset malignancy were 4.2, 2.9, and 2.6 per 100 person-year among the non-recovery, the recovery, and the non-AKI group, respectively. After adjustment, the recovery group was more likely to develop long-term de novo malignancy than those without AKI [hazard ratio (HR) 1.44, 95% confidence interval (CI) 1.02-2.03; p = 0.04], while less likely than those who did not recover (HR 0.66, 95% CI 0.45-0.98; p = 0.04).
Dialysis-requiring AKI can post a long-term risk of de novo malignancy for those who survive from the initial insult. Even patients who have recovered from dialysis still carry a significantly higher possibility of developing malignancy than those without AKI episode.
急性肾损伤(AKI)最近受到全球关注,成为主要的公共卫生威胁。然而,AKI 的发展与随后发生恶性肿瘤之间的关系尚未被研究过。
我们进行了一项基于台湾全民健康保险数据库的人群研究,使用 2000 年至 2008 年期间的 100 万代表性数据库。所有从需要透析的 AKI 指数住院中出院并恢复的患者(恢复组),均与未恢复、未发生 AKI 的患者以 1:1:1 的比例进行匹配。
我们确定了 625 名年龄超过 18 岁的患者[352 名男性(56.5%);平均年龄 63.3 岁]在恢复组,并与每组中的 625 名患者相匹配。在平均 3.7 年的随访期间,非恢复组、恢复组和非 AKI 组新发恶性肿瘤的发生率分别为每 100 人年 4.2、2.9 和 2.6 例。调整后,与无 AKI 患者相比,恢复组发生长期新发恶性肿瘤的风险更高[风险比(HR)1.44,95%置信区间(CI)1.02-2.03;p=0.04],但比未恢复的患者发生的可能性更小(HR 0.66,95% CI 0.45-0.98;p=0.04)。
对于那些从初始损伤中存活下来的患者,需要透析的 AKI 可带来长期新发恶性肿瘤的风险。即使是从透析中恢复的患者,发生恶性肿瘤的可能性也明显高于无 AKI 发作的患者。